Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Carbone

Showing results (71-80 of 283) with videos related to

Pageof 29
Sort By:
Journal of Hematology & Oncology|June 20, 2019
DLL3: an emerging target in small cell lung cancerDwight H Owen, Michael J Giffin, Julie M Bailis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKTJacob M Kaufman, Joseph M Amann, Kyungho Park, et al.
Blood|March 23, 2007
Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGFYuhui Huang, Xiaolan Chen, Mikhail M Dikov, et al.
Nature Reviews. Disease Primers|May 19, 2016
Non-small-cell lung cancerCesare Gridelli, Antonio Rossi, David P Carbone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometryJoseph M Amann, Pierre Chaurand, Adriana Gonzalez, et al.
JTO Clinical and Research Reports|April 20, 2026
Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and BrazilMasahiro Fujioka, Toshihiko Aranishi, Takehito Shukuya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLCTakehito Shukuya, Vikas Ghai, Joseph M Amann, et al.
Clinical Lung Cancer|July 10, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung CancerAshwini Arunachalam, Haojie Li, Marisa A Bittoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung CancerTakehito Shukuya, Tadaaki Yamada, Michael J Koenig, et al.
Pageof 29

Showing results (71-80 of 283) with videos related to

Sort By:
Pageof 29
Journal of Hematology & Oncology|June 20, 2019
DLL3: an emerging target in small cell lung cancerDwight H Owen, Michael J Giffin, Julie M Bailis, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 16, 2014
LKB1 Loss induces characteristic patterns of gene expression in human tumors associated with NRF2 activation and attenuation of PI3K-AKTJacob M Kaufman, Joseph M Amann, Kyungho Park, et al.
Blood|March 23, 2007
Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGFYuhui Huang, Xiaolan Chen, Mikhail M Dikov, et al.
Nature Reviews. Disease Primers|May 19, 2016
Non-small-cell lung cancerCesare Gridelli, Antonio Rossi, David P Carbone, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2010
Anti-vascular endothelial growth factor treatment in combination with chemotherapy delays hematopoietic recovery due to decreased proliferation of bone marrow hematopoietic progenitor cellsSergey V Novitskiy, Ildiko Csiki, Yuhui Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 5, 2006
Selective profiling of proteins in lung cancer cells from fine-needle aspirates by matrix-assisted laser desorption ionization time-of-flight mass spectrometryJoseph M Amann, Pierre Chaurand, Adriana Gonzalez, et al.
JTO Clinical and Research Reports|April 20, 2026
Cost-Effectiveness of Perioperative Immune Checkpoint Therapy for NSCLC in Japan, the United States, and BrazilMasahiro Fujioka, Toshihiko Aranishi, Takehito Shukuya, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 23, 2020
Circulating MicroRNAs and Extracellular Vesicle-Containing MicroRNAs as Response Biomarkers of Anti-programmed Cell Death Protein 1 or Programmed Death-Ligand 1 Therapy in NSCLCTakehito Shukuya, Vikas Ghai, Joseph M Amann, et al.
Clinical Lung Cancer|July 10, 2018
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With Advanced Non-Small-Cell Lung CancerAshwini Arunachalam, Haojie Li, Marisa A Bittoni, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung CancerTakehito Shukuya, Tadaaki Yamada, Michael J Koenig, et al.
Pageof 29